Michaela Malko
Nurse Practitioner · Monroe, MINPI 1982273256
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (54.8%), education and travel and lodging — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Spinal Simplicity, LLC at 33.5% of the total. Reporting peaked in 2021 at $3,245 and has fallen 80.9% since, to $619 in 2023. Among nurse practitioner clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 135 payments — averaging $49.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Spinal Simplicity, LLC$2K
- Neuronetics, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$641
- Lundbeck LLC$607
- Otsuka America Pharmaceutical, Inc.$395
- Amgen$320
- plus $1K from 19 others
What the payments were for
- Travel & lodging$1,01015%
- Food & beverage$3,64255%
- Education$1,99730%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Spinal Simplicity, LLC | 3 | $2,230 |
| Neuronetics, Inc. | 2 | $1,118 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 29 | $641 |
| Lundbeck LLC | 36 | $607 |
| Otsuka America Pharmaceutical, Inc. | 9 | $395 |
| Amgen(2 entities) | 7 | $320 |
| AbbVie(2 entities) | 15 | $279 |
| Nevro Corp. | 1 | $141 |
| Idorsia Pharmaceuticals US Inc | 2 | $141 |
| AstraZeneca(2 entities) | 3 | $115 |
| SPR Therapeutics, Inc | 1 | $115 |
| Johnson & Johnson | 3 | $107 |
| Avanir Pharmaceuticals, Inc. | 2 | $53 |
| Vanda Pharmaceuticals Inc. | 3 | $53 |
| Neurocrine Biosciences, Inc. | 2 | $44 |
| Lilly USA, LLC | 3 | $43 |
| Supernus Pharmaceuticals, Inc. | 2 | $40 |
| Indivior Inc. | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $34 |
| Alkermes, Inc. | 2 | $33 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
| GRT US Holding, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HA MINUTEMAN G3-R$2,216
- NEUROSTAR TMS THERAPY SYSTEM$1,118
- RAYOS$375
- REXULTI$338
- CAPLYTA$250
- Omnia$141
- AIMOVIG$125
- VRAYLAR$125
- QUVIVIQ$125
- SPRINT PNS System$115
How this compares
$6,649 in reported general payments places this provider in the 95th percentile of 3,351 nurse practitioner providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate | 70 | $1,199 |
| Naltrexone Hcl | 11 | $524 |
| Propranolol Hcl | 12 | $341 |
| Olanzapine | 16 | $339 |
| Clonidine Hcl | 12 | $80 |
| Fluoxetine Hcl | 12 | $65 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCOlanzapine | $43 | $33916 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,351 nurse practitioner providers in Michigan.
Other nurse practitioner in Monroe
- Davida KrugerDetroit$739K
- Kari HillSpring Lake$426K
- Kyle FarrPlymouth$243K
- Linda SpencerTroy$217K
- Ellen DillardDetroit$168K
- Golbon AghamohammadiDetroit$157K
- Abubakir BabanDearborn$143K
- Lisa Astalos ChismWoodhaven$103K
- Martha GoetzPetoskey$101K
- Debra DegraffGrand Rapids$80K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.